205 related articles for article (PubMed ID: 15823454)
1. Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease.
Tsoumakidou M; Tzanakis N; Chrysofakis G; Kyriakou D; Siafakas NM
Respir Med; 2005 May; 99(5):572-9. PubMed ID: 15823454
[TBL] [Abstract][Full Text] [Related]
2. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.
Barczyk A; Pierzchała W; Kon OM; Cosio B; Adcock IM; Barnes PJ
J Allergy Clin Immunol; 2006 Jun; 117(6):1484-92. PubMed ID: 16751017
[TBL] [Abstract][Full Text] [Related]
4. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
Domagała-Kulawik J; Hoser G; Dabrowska M; Chazan R
Respir Med; 2007 Jun; 101(6):1338-43. PubMed ID: 17118637
[TBL] [Abstract][Full Text] [Related]
5. Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease.
Tzanakis N; Chrysofakis G; Tsoumakidou M; Kyriakou D; Tsiligianni J; Bouros D; Siafakas NM
Respir Med; 2004 Jan; 98(1):57-65. PubMed ID: 14959815
[TBL] [Abstract][Full Text] [Related]
6. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD.
Shirai T; Suda T; Inui N; Chida K
Allergol Int; 2010 Mar; 59(1):75-82. PubMed ID: 20035145
[TBL] [Abstract][Full Text] [Related]
7. Tc2 response at the onset of COPD exacerbations.
Makris D; Lazarou S; Alexandrakis M; Kourelis TV; Tzanakis N; Kyriakou D; Gourgoulianis KI
Chest; 2008 Sep; 134(3):483-488. PubMed ID: 18490406
[TBL] [Abstract][Full Text] [Related]
8. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
9. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
[TBL] [Abstract][Full Text] [Related]
10. Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease.
Tsoumakidou M; Bouloukaki I; Koutala H; Kouvidi K; Mitrouska I; Zakynthinos S; Tzanakis N; Jeffery PK; Siafakas NM
Int Arch Allergy Immunol; 2009; 150(4):389-97. PubMed ID: 19571571
[TBL] [Abstract][Full Text] [Related]
11. Increased intraepithelial T-cells in stable COPD.
Löfdahl MJ; Roos-Engstrand E; Pourazar J; Bucht A; Dahlen B; Elmberger G; Blomberg A; Sköld CM
Respir Med; 2008 Dec; 102(12):1812-8. PubMed ID: 18706796
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.
Jeffery PK
Novartis Found Symp; 2001; 234():149-61; discussion 161-8. PubMed ID: 11199094
[TBL] [Abstract][Full Text] [Related]
13. CD8(+) Tc-lymphocytes immunodeviation in peripheral blood and airway from patients of chronic obstructive pulmonary disease and changes after short-term smoking cessation.
Yu MQ; Liu XS; Wang JM; Xu YJ
Chin Med J (Engl); 2013; 126(19):3608-15. PubMed ID: 24112150
[TBL] [Abstract][Full Text] [Related]
14. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
15. [Profiles of type 1 and type 2 T cells in chronic idiopathic thrombocytopenic purpura].
Wang TT; Zhao H; Ren H; Guo JH; Xu MQ; Yang RC; Han ZC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):669-73. PubMed ID: 16681922
[TBL] [Abstract][Full Text] [Related]
16. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
17. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
[TBL] [Abstract][Full Text] [Related]
18. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma.
Tsoumakidou M; Tzanakis N; Kyriakou D; Chrysofakis G; Siafakas NM
Clin Exp Allergy; 2004 Feb; 34(2):234-40. PubMed ID: 14987303
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
